Literature DB >> 20030564

Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006.

Marc S Hoffmann1, Michael R Eber, Ramanan Laxminarayan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20030564     DOI： 10.1086/650379

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  12 in total

1.  White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens.

Authors: 
Journal:  Clin Infect Dis       Date:  2012-08-13       Impact factor: 9.079

2.  Combating antimicrobial resistance: policy recommendations to save lives.

Authors:  Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

3.  The Multidrug-Resistant Gram-negative Superbugs Threat Require Intelligent Use of the Last Weapon.

Authors:  Zakuan Zainy Deris
Journal:  Malays J Med Sci       Date:  2015-09

4.  Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?

Authors:  Anna de Breij; Lenie Dijkshoorn; Ellen Lagendijk; Joke van der Meer; Abraham Koster; Guido Bloemberg; Ron Wolterbeek; Peterhans van den Broek; Peter Nibbering
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

5.  The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.

Authors:  Laure Diancourt; Virginie Passet; Alexandr Nemec; Lenie Dijkshoorn; Sylvain Brisse
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

6.  Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.

Authors:  Lin Lin; Brandon Tan; Paul Pantapalangkoor; Tiffany Ho; Andrea M Hujer; Magdalena A Taracila; Robert A Bonomo; Brad Spellberg
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

7.  Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012.

Authors:  Larissa May; Eili Y Klein; Richard E Rothman; Ramanan Laxminarayan
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

8.  Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.

Authors:  Guanpingshen Luo; Lin Lin; Ashraf S Ibrahim; Beverlie Baquir; Paul Pantapalangkoor; Robert A Bonomo; Yohei Doi; Mark D Adams; Thomas A Russo; Brad Spellberg
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

9.  Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections.

Authors:  Marin L Schweizer; Eli N Perencevich; Michael R Eber; Xueya Cai; Michelle D Shardell; Nikolay Braykov; Ramanan Laxminarayan
Journal:  Antimicrob Resist Infect Control       Date:  2013-10-15       Impact factor: 4.887

10.  Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.

Authors:  Lin Lin; Brandon Tan; Paul Pantapalangkoor; Tiffany Ho; Beverlie Baquir; Andrew Tomaras; Justin I Montgomery; Usa Reilly; Elsa G Barbacci; Kristine Hujer; Robert A Bonomo; Lucia Fernandez; Robert E W Hancock; Mark D Adams; Samuel W French; Virgil S Buslon; Brad Spellberg
Journal:  MBio       Date:  2012-10-02       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.